These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients. Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700 [TBL] [Abstract][Full Text] [Related]
5. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings]. Brown WA; Haier RJ; Qualls CB Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667 [No Abstract] [Full Text] [Related]
6. Imipramine in prepubertal major depressive disorders. Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Tabrizi MA; King J; Goetz R; Davies M; Stiller RL Arch Gen Psychiatry; 1987 Jan; 44(1):81-9. PubMed ID: 3541830 [TBL] [Abstract][Full Text] [Related]
7. Evidence for in vivo methylation of the secondary amino antidepressant desipramine to imipramine in humans. Narasimhachari N; Saady JJ; Joseph A; Ettigi P; Friedel RO J Clin Psychopharmacol; 1982 Dec; 2(6):413-6. PubMed ID: 7174866 [No Abstract] [Full Text] [Related]
8. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report. Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Shea C; Tabrizi MA; Stiller RL J Am Acad Child Psychiatry; 1979; 18(4):616-27. PubMed ID: 541469 [No Abstract] [Full Text] [Related]
12. Plasma concentrations of imipramine and clinical response among depressed outpatients. Matuzas W; Javaid JI; Glass R; Davis JM; Ross JA; Uhlenhuth EH J Clin Psychopharmacol; 1982 Apr; 2(2):140-2. PubMed ID: 7042772 [No Abstract] [Full Text] [Related]
13. Depression, agoraphobia, and the DST. Stewart JT; Lawlor BA J Clin Psychiatry; 1985 Nov; 46(11):503-4. PubMed ID: 4055714 [No Abstract] [Full Text] [Related]
14. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. Stark P; Hardison CD J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682 [TBL] [Abstract][Full Text] [Related]
15. Imipramine treatment of depressed children: a double-blind pilot study. Petti TA; Law W J Clin Psychopharmacol; 1982 Apr; 2(2):107-10. PubMed ID: 7042769 [No Abstract] [Full Text] [Related]
16. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison [proceedings]. Quitkin FM; Kane JM; Rifkin A; Ramos-Lorenzi JR; Saraf K; Howard A; Klein DF Psychopharmacol Bull; 1981 Jan; 17(1):142-4. PubMed ID: 7015396 [No Abstract] [Full Text] [Related]
17. Plasma concentration and clinical effect in imipramine treatment of childhood enuresis. Jorgensen OS; Lober M; Christiansen J; Gram LF Clin Pharmacokinet; 1980; 5(4):386-93. PubMed ID: 6994982 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of imipramine and adverse effects in children. Preskorn SH; Weller EB; Weller RA; Glotzbach E Am J Psychiatry; 1983 Oct; 140(10):1332-5. PubMed ID: 6624965 [TBL] [Abstract][Full Text] [Related]
19. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358 [TBL] [Abstract][Full Text] [Related]
20. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients. Merideth CH; Feighner JP; Hendrickson G J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]